COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,871 Articles (22,568 medRxiv, 8,303 bioRxiv)

Most recent first Previous |  Page 854: Articles 8531-8540  | Next

SARS-CoV-2 Omicron Variant Infection of Individuals with High Titer Neutralizing Antibodies Post-3rd mRNA Vaccine Dose
Roeder, A. J., Koehler, M. A., Svarovsky, S., Jasbi, P., Seit-Nebi, A., Gonzalez-Moa, M. J., Vanderhoof, J., Mckechnie, D., Edwards, B. A., Lake, D. F.
10.1101/2022.03.03.22270812 — Posted: 2022-03-06
Zonal Model of Aerosol Persistence in ICUs: Utilization of Time and Space-resolved Sensor Network
Glenn, K., He, J., Rochlin, R., Teng, S., Hecker, J., Novosselov, I.
10.1101/2022.03.03.22271831 — Posted: 2022-03-06
Reasons underlying the intention to vaccinate children aged 5-11 against COVID-19: A cross-sectional study of parents in Israel, November 2021
Morozov, N., Dror, A. A., Daoud, A., Eisenbach, N., Kaykov, E., Barhoum, M., Sheleg, T., Edelstein, M.
10.1101/2022.03.03.22271793 — Posted: 2022-03-06
The relationship between BMI and COVID-19: exploring misclassification and selection bias in a two-sample Mendelian randomisation study
Clayton, G. L., Goncalves Soares, A., Goulding, N., Borges, M. C. G., Holmes, M., Davey Smith, G., Tilling, K., Lawlor, D. A., Carter, A. R.
10.1101/2022.03.03.22271836 — Posted: 2022-03-05
Covid-19 Exposure Assessment Tool (CEAT): Easy-to-use tool to quantify exposure based on airflow, group behavior, and infection prevalence in the community
Schimmoller, B., Trovao, N. S., Isbell, M., Goel, C., Heck, B. F., Archer, T. C., Cardinal, K. D., Naik, N. B., Dutta, S., Rohr Daniel, A., Beheshti, A.
10.1101/2022.03.02.22271806 — Posted: 2022-03-05
Association between COVID-19 Risk-Mitigation Behaviors and Specific Mental Disorders in Youth
Conway, K., Bhardwaj, K., Michel, E., Paksarian, D., Nikolaidis, A., Kang, M., Merikangas, K. R., Milham, M.
10.1101/2022.03.03.22271787 — Posted: 2022-03-05
Precision recruitment for high-risk participants in a COVID-19 research study
Mezlini, A., Caddigan, E., Shapiro, A., Ramirez, E., Kondow-McConaghy, H., Yang, J., DeMarco, K., Naraghi-Arani, P., Foschini, L.
10.1101/2022.03.03.22271504 — Posted: 2022-03-05
Acute and long-term impacts of COVID-19 on economic vulnerability: a population-based longitudinal study (COVIDENCE UK)
Williamson, A. E., Tydeman, F., Miners, A., Pyper, K., Martineau, A. R.
10.1101/2022.03.03.22271835 — Posted: 2022-03-04
Zinc pyrithione is a potent inhibitor of PLPro and cathepsin L enzymes with ex vivo inhibition of SARS-CoV-2 entry and replication
Kladnik, J., Dolinar, A., Kljun, J., Perea, D., Grau-Exposito, J., Genesca, M., Novinec, M., Buzon, M. J., Turel, I.
10.1101/2022.03.03.482819 — Posted: 2022-03-04
The interaction of calcium ions with specific residues in the SARS-CoV fusion peptide and the regulation of viral infectivity
Bidon, M. K., Khelashvili, G., Straus, M., Tang, T., Carten, J., Weinstein, H., Whittaker, G., Daniel, S.
10.1101/2022.03.03.482731 — Posted: 2022-03-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).